

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by symbiont of host defense response (GO:0052031) | 5.87498025 |
| 2 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.87498025 |
| 3 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.87498025 |
| 4 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.87498025 |
| 5 | modulation by symbiont of host immune response (GO:0052553) | 5.87498025 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 5.87498025 |
| 7 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.84789739 |
| 8 | negative regulation of cell killing (GO:0031342) | 5.84789739 |
| 9 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.73877555 |
| 10 | neutrophil activation involved in immune response (GO:0002283) | 5.45449515 |
| 11 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.90696702 |
| 12 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.84754001 |
| 13 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.80016586 |
| 14 | hydrogen peroxide biosynthetic process (GO:0050665) | 4.71840442 |
| 15 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.67793094 |
| 16 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.62771967 |
| 17 | response to peptidoglycan (GO:0032494) | 4.52517008 |
| 18 | macrophage activation involved in immune response (GO:0002281) | 4.36520338 |
| 19 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.34658656 |
| 20 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.28553697 |
| 21 | regulation of gamma-delta T cell activation (GO:0046643) | 4.19856335 |
| 22 | detection of bacterium (GO:0016045) | 4.19394007 |
| 23 | respiratory burst (GO:0045730) | 4.15765487 |
| 24 | reactive oxygen species biosynthetic process (GO:1903409) | 4.14172750 |
| 25 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.04068706 |
| 26 | superoxide anion generation (GO:0042554) | 3.99714633 |
| 27 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.99178463 |
| 28 | response to interleukin-15 (GO:0070672) | 3.98030476 |
| 29 | aldehyde catabolic process (GO:0046185) | 3.90729488 |
| 30 | response to host immune response (GO:0052572) | 3.87972329 |
| 31 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.87972329 |
| 32 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.86985100 |
| 33 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.77974708 |
| 34 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.77447836 |
| 35 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.76417223 |
| 36 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.71611457 |
| 37 | positive regulation of interferon-alpha production (GO:0032727) | 3.71432250 |
| 38 | immunoglobulin mediated immune response (GO:0016064) | 3.65333076 |
| 39 | negative regulation of T cell mediated immunity (GO:0002710) | 3.62608861 |
| 40 | detection of molecule of bacterial origin (GO:0032490) | 3.60553891 |
| 41 | microglial cell activation (GO:0001774) | 3.59282245 |
| 42 | granulocyte activation (GO:0036230) | 3.58884284 |
| 43 | cellular response to interleukin-15 (GO:0071350) | 3.57863099 |
| 44 | regulation of interferon-alpha production (GO:0032647) | 3.56484948 |
| 45 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.54472802 |
| 46 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.54368212 |
| 47 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.51724522 |
| 48 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.50531114 |
| 49 | cellular response to type I interferon (GO:0071357) | 3.46940808 |
| 50 | type I interferon signaling pathway (GO:0060337) | 3.46940808 |
| 51 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.45569062 |
| 52 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.45355115 |
| 53 | response to type I interferon (GO:0034340) | 3.44272065 |
| 54 | neutrophil activation (GO:0042119) | 3.40475700 |
| 55 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.39503422 |
| 56 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.36231226 |
| 57 | response to host (GO:0075136) | 3.36231226 |
| 58 | response to host defenses (GO:0052200) | 3.36231226 |
| 59 | myeloid leukocyte mediated immunity (GO:0002444) | 3.35636373 |
| 60 | positive regulation of heat generation (GO:0031652) | 3.28229375 |
| 61 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 3.27655142 |
| 62 | regulation of tolerance induction (GO:0002643) | 3.24126475 |
| 63 | regulation of T cell tolerance induction (GO:0002664) | 3.22539554 |
| 64 | macrophage activation (GO:0042116) | 3.22139106 |
| 65 | B cell receptor signaling pathway (GO:0050853) | 3.18382673 |
| 66 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.18225345 |
| 67 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.18225345 |
| 68 | regulation of cholesterol storage (GO:0010885) | 3.18149980 |
| 69 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.17688894 |
| 70 | low-density lipoprotein particle clearance (GO:0034383) | 3.15711430 |
| 71 | negative T cell selection (GO:0043383) | 3.13780440 |
| 72 | regulation of fever generation (GO:0031620) | 3.13656259 |
| 73 | regulation of mononuclear cell migration (GO:0071675) | 3.12644642 |
| 74 | germinal center formation (GO:0002467) | 3.10759774 |
| 75 | negative thymic T cell selection (GO:0045060) | 3.10662449 |
| 76 | plasma lipoprotein particle clearance (GO:0034381) | 3.09646866 |
| 77 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.09391028 |
| 78 | natural killer cell mediated immunity (GO:0002228) | 3.09391028 |
| 79 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.09305228 |
| 80 | myeloid cell activation involved in immune response (GO:0002275) | 3.08605391 |
| 81 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.07857531 |
| 82 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.05703443 |
| 83 | negative regulation of lipid storage (GO:0010888) | 3.00138935 |
| 84 | regulation of B cell differentiation (GO:0045577) | 2.99842841 |
| 85 | positive regulation of B cell differentiation (GO:0045579) | 2.99252107 |
| 86 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.99250329 |
| 87 | response to protozoan (GO:0001562) | 2.98823143 |
| 88 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.97511537 |
| 89 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.97298225 |
| 90 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.96609729 |
| 91 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.94361424 |
| 92 | regulation of chemokine biosynthetic process (GO:0045073) | 2.94178084 |
| 93 | response to muramyl dipeptide (GO:0032495) | 2.93529037 |
| 94 | regulation of regulatory T cell differentiation (GO:0045589) | 2.93423908 |
| 95 | dendritic cell migration (GO:0036336) | 2.92890437 |
| 96 | positive regulation of interferon-beta production (GO:0032728) | 2.92622159 |
| 97 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.92034260 |
| 98 | myeloid leukocyte activation (GO:0002274) | 2.90554750 |
| 99 | positive regulation of mast cell degranulation (GO:0043306) | 2.89876432 |
| 100 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.89876432 |
| 101 | detection of external biotic stimulus (GO:0098581) | 2.89532907 |
| 102 | leukocyte mediated cytotoxicity (GO:0001909) | 2.89119733 |
| 103 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.88304798 |
| 104 | protein carboxylation (GO:0018214) | 2.88304798 |
| 105 | detection of other organism (GO:0098543) | 2.88259998 |
| 106 | cellular extravasation (GO:0045123) | 2.88025553 |
| 107 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.87787850 |
| 108 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.87556307 |
| 109 | tolerance induction (GO:0002507) | 2.87266510 |
| 110 | T cell migration (GO:0072678) | 2.86811039 |
| 111 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.85996659 |
| 112 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.84612808 |
| 113 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.84559954 |
| 114 | leukocyte degranulation (GO:0043299) | 2.84141595 |
| 115 | positive thymic T cell selection (GO:0045059) | 2.83151757 |
| 116 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.82923075 |
| 117 | negative regulation of adaptive immune response (GO:0002820) | 2.80231713 |
| 118 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.79993226 |
| 119 | negative regulation of interleukin-12 production (GO:0032695) | 2.79848723 |
| 120 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.78578045 |
| 121 | regulation of leukocyte degranulation (GO:0043300) | 2.78549760 |
| 122 | leukocyte aggregation (GO:0070486) | 2.75681699 |
| 123 | positive regulation of mast cell activation (GO:0033005) | 2.74227173 |
| 124 | T-helper 1 type immune response (GO:0042088) | 2.73702189 |
| 125 | I-kappaB phosphorylation (GO:0007252) | 2.72196865 |
| 126 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.71329851 |
| 127 | regulation of mast cell degranulation (GO:0043304) | 2.68638951 |
| 128 | positive regulation of leukocyte degranulation (GO:0043302) | 2.66514114 |
| 129 | positive regulation of antigen processing and presentation (GO:0002579) | 2.66319515 |
| 130 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.65742044 |
| 131 | cytokine secretion (GO:0050663) | 2.65590255 |
| 132 | B cell mediated immunity (GO:0019724) | 2.61597814 |
| 133 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.59774734 |
| 134 | positive regulation of chemokine production (GO:0032722) | 2.59653870 |
| 135 | detection of biotic stimulus (GO:0009595) | 2.59463894 |
| 136 | negative regulation of interleukin-17 production (GO:0032700) | 2.59315228 |
| 137 | positive regulation of lipid storage (GO:0010884) | 2.59247091 |
| 138 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.55036885 |
| 139 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.53751607 |
| 140 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 2.52197717 |
| 141 | positive regulation of interleukin-6 production (GO:0032755) | 2.51905745 |
| 142 | phagosome maturation (GO:0090382) | 2.51735587 |
| 143 | positive regulation of acute inflammatory response (GO:0002675) | 2.50712289 |
| 144 | regulation of mast cell activation (GO:0033003) | 2.50520315 |
| 145 | regulation of heat generation (GO:0031650) | 2.50266306 |
| 146 | neutrophil mediated immunity (GO:0002446) | 2.49792546 |
| 147 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.48842984 |
| 148 | acute-phase response (GO:0006953) | 2.44108014 |
| 149 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.43929520 |
| 150 | defense response to protozoan (GO:0042832) | 2.43769893 |
| 151 | positive regulation of coagulation (GO:0050820) | 2.43179886 |
| 152 | cell killing (GO:0001906) | 2.43177102 |
| 153 | positive regulation of blood coagulation (GO:0030194) | 2.42317248 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.85026554 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.55877671 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.29277673 |
| 4 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.51207186 |
| 5 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 4.14274632 |
| 6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.98271111 |
| 7 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.85224537 |
| 8 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.52086096 |
| 9 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.28614503 |
| 10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.15451195 |
| 11 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.11203364 |
| 12 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.01261665 |
| 13 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.88320711 |
| 14 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.87974284 |
| 15 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.78812682 |
| 16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.75494245 |
| 17 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.68113284 |
| 18 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.62678551 |
| 19 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.47362084 |
| 20 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.45621943 |
| 21 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.39905577 |
| 22 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.25059509 |
| 23 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.22475901 |
| 24 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.20197068 |
| 25 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.18261545 |
| 26 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.11094911 |
| 27 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.06251522 |
| 28 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.04503227 |
| 29 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.00753857 |
| 30 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.94693189 |
| 31 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.89612523 |
| 32 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.87862623 |
| 33 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.87776832 |
| 34 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.86503688 |
| 35 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.83168524 |
| 36 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.81720445 |
| 37 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.80770975 |
| 38 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.74808002 |
| 39 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.69172168 |
| 40 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.64813324 |
| 41 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.61336832 |
| 42 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.61310036 |
| 43 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.59105082 |
| 44 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.58670860 |
| 45 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.54487761 |
| 46 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.53389881 |
| 47 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.52870389 |
| 48 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.52493734 |
| 49 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.51306400 |
| 50 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.50105056 |
| 51 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.47564987 |
| 52 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.47333217 |
| 53 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.47333217 |
| 54 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.43723585 |
| 55 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.43247807 |
| 56 | GATA1_22025678_ChIP-Seq_K562_Human | 1.41606393 |
| 57 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38435175 |
| 58 | MAF_26560356_Chip-Seq_TH2_Human | 1.37659217 |
| 59 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.36392195 |
| 60 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.36130606 |
| 61 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.34621976 |
| 62 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.30165153 |
| 63 | MYC_22102868_ChIP-Seq_BL_Human | 1.25800218 |
| 64 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.24356503 |
| 65 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.24242118 |
| 66 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20206804 |
| 67 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.19046756 |
| 68 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.18994384 |
| 69 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.18206853 |
| 70 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17345030 |
| 71 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.14678715 |
| 72 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.14514367 |
| 73 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.14366475 |
| 74 | GATA1_19941826_ChIP-Seq_K562_Human | 1.13834807 |
| 75 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.11841066 |
| 76 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11297744 |
| 77 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.10976350 |
| 78 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.09597875 |
| 79 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.08108284 |
| 80 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07854465 |
| 81 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.07672886 |
| 82 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07365464 |
| 83 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.07326922 |
| 84 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04698092 |
| 85 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.04305655 |
| 86 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.04072315 |
| 87 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.03206354 |
| 88 | * MYB_26560356_Chip-Seq_TH2_Human | 1.03130736 |
| 89 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.02468898 |
| 90 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.02261980 |
| 91 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.02261980 |
| 92 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.02079790 |
| 93 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.01977834 |
| 94 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.01447677 |
| 95 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.01137638 |
| 96 | GATA2_19941826_ChIP-Seq_K562_Human | 1.01041711 |
| 97 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 0.99681271 |
| 98 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.99586945 |
| 99 | GATA3_26560356_Chip-Seq_TH2_Human | 0.99067366 |
| 100 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98375438 |
| 101 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.97804962 |
| 102 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96936761 |
| 103 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.96834405 |
| 104 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.96167626 |
| 105 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95025166 |
| 106 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94548557 |
| 107 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.93930387 |
| 108 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.93753713 |
| 109 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93358533 |
| 110 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.93298093 |
| 111 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.93267682 |
| 112 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.93241772 |
| 113 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.93239653 |
| 114 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91180503 |
| 115 | * MYB_26560356_Chip-Seq_TH1_Human | 0.89183988 |
| 116 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.88145591 |
| 117 | CJUN_26792858_Chip-Seq_BT549_Human | 0.87561040 |
| 118 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.86325444 |
| 119 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.86038814 |
| 120 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.85321967 |
| 121 | SPI1_23127762_ChIP-Seq_K562_Human | 0.85065170 |
| 122 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.84851295 |
| 123 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.84845527 |
| 124 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.84293313 |
| 125 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.83164126 |
| 126 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.82829964 |
| 127 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82530379 |
| 128 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.82419752 |
| 129 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.81676530 |
| 130 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.81091198 |
| 131 | MAF_26560356_Chip-Seq_TH1_Human | 0.80726927 |
| 132 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.80338336 |
| 133 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.79677069 |
| 134 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.79613306 |
| 135 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.76198534 |
| 136 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 0.74901375 |
| 137 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.74554810 |
| 138 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.74009065 |
| 139 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72140997 |
| 140 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.68205344 |
| 141 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.67640765 |
| 142 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.64362849 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003436_decreased_susceptibility_to | 3.64743481 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.36979467 |
| 3 | MP0005058_abnormal_lysosome_morphology | 3.10844728 |
| 4 | MP0002139_abnormal_hepatobiliary_system | 3.10396870 |
| 5 | MP0009785_altered_susceptibility_to | 3.07551941 |
| 6 | MP0003303_peritoneal_inflammation | 3.05092052 |
| 7 | MP0006082_CNS_inflammation | 2.95255597 |
| 8 | MP0002419_abnormal_innate_immunity | 2.81617341 |
| 9 | MP0003724_increased_susceptibility_to | 2.77600541 |
| 10 | MP0002148_abnormal_hypersensitivity_rea | 2.70429097 |
| 11 | MP0005360_urolithiasis | 2.44113757 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.43257995 |
| 13 | MP0005025_abnormal_response_to | 2.42662355 |
| 14 | MP0009764_decreased_sensitivity_to | 2.33427904 |
| 15 | MP0009840_abnormal_foam_cell | 2.27375459 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.24961862 |
| 17 | MP0003763_abnormal_thymus_physiology | 2.18658171 |
| 18 | MP0001533_abnormal_skeleton_physiology | 2.05960623 |
| 19 | MP0003195_calcinosis | 2.04599250 |
| 20 | MP0002452_abnormal_antigen_presenting | 1.97156326 |
| 21 | MP0001790_abnormal_immune_system | 1.96179978 |
| 22 | MP0005387_immune_system_phenotype | 1.96179978 |
| 23 | MP0005085_abnormal_gallbladder_physiolo | 1.94759680 |
| 24 | MP0005464_abnormal_platelet_physiology | 1.92687572 |
| 25 | MP0004510_myositis | 1.89783330 |
| 26 | MP0002723_abnormal_immune_serum | 1.83854489 |
| 27 | MP0002398_abnormal_bone_marrow | 1.79178733 |
| 28 | MP0005365_abnormal_bile_salt | 1.76865128 |
| 29 | MP0008469_abnormal_protein_level | 1.75257405 |
| 30 | MP0003075_altered_response_to | 1.74650288 |
| 31 | MP0000465_gastrointestinal_hemorrhage | 1.74227977 |
| 32 | MP0003186_abnormal_redox_activity | 1.74004655 |
| 33 | MP0001845_abnormal_inflammatory_respons | 1.73618122 |
| 34 | MP0004947_skin_inflammation | 1.73540531 |
| 35 | MP0004883_abnormal_blood_vessel | 1.68741154 |
| 36 | MP0001800_abnormal_humoral_immune | 1.67849944 |
| 37 | MP0005083_abnormal_biliary_tract | 1.63545365 |
| 38 | MP0000685_abnormal_immune_system | 1.62958007 |
| 39 | MP0003172_abnormal_lysosome_physiology | 1.62881749 |
| 40 | MP0002132_abnormal_respiratory_system | 1.61131277 |
| 41 | MP0000343_altered_response_to | 1.60861106 |
| 42 | MP0003300_gastrointestinal_ulcer | 1.59071988 |
| 43 | MP0008875_abnormal_xenobiotic_pharmacok | 1.57550042 |
| 44 | MP0005166_decreased_susceptibility_to | 1.57486703 |
| 45 | MP0000604_amyloidosis | 1.57076901 |
| 46 | MP0005310_abnormal_salivary_gland | 1.55330041 |
| 47 | MP0002254_reproductive_system_inflammat | 1.55273445 |
| 48 | MP0003448_altered_tumor_morphology | 1.55130015 |
| 49 | MP0001853_heart_inflammation | 1.51495888 |
| 50 | MP0001819_abnormal_immune_cell | 1.51351669 |
| 51 | MP0002722_abnormal_immune_system | 1.51036422 |
| 52 | MP0004381_abnormal_hair_follicle | 1.50465689 |
| 53 | MP0000569_abnormal_digit_pigmentation | 1.50227545 |
| 54 | MP0003866_abnormal_defecation | 1.48581597 |
| 55 | MP0002420_abnormal_adaptive_immunity | 1.47960176 |
| 56 | MP0002006_tumorigenesis | 1.42156470 |
| 57 | MP0002138_abnormal_hepatobiliary_system | 1.40770440 |
| 58 | MP0005671_abnormal_response_to | 1.40741612 |
| 59 | MP0002429_abnormal_blood_cell | 1.40736662 |
| 60 | MP0010155_abnormal_intestine_physiology | 1.36630657 |
| 61 | MP0002405_respiratory_system_inflammati | 1.35726217 |
| 62 | MP0002998_abnormal_bone_remodeling | 1.35551170 |
| 63 | MP0004782_abnormal_surfactant_physiolog | 1.33823645 |
| 64 | MP0002396_abnormal_hematopoietic_system | 1.33614980 |
| 65 | MP0003690_abnormal_glial_cell | 1.32970064 |
| 66 | MP0005164_abnormal_response_to | 1.32886326 |
| 67 | MP0005167_abnormal_blood-brain_barrier | 1.30435527 |
| 68 | MP0000703_abnormal_thymus_morphology | 1.28824361 |
| 69 | MP0003252_abnormal_bile_duct | 1.27632286 |
| 70 | MP0005451_abnormal_body_composition | 1.25885288 |
| 71 | MP0003656_abnormal_erythrocyte_physiolo | 1.25602988 |
| 72 | MP0010329_abnormal_lipoprotein_level | 1.21779896 |
| 73 | MP0000609_abnormal_liver_physiology | 1.18495539 |
| 74 | MP0005319_abnormal_enzyme/_coenzyme | 1.18116296 |
| 75 | MP0009763_increased_sensitivity_to | 1.15640924 |
| 76 | MP0008260_abnormal_autophagy | 1.14906296 |
| 77 | MP0003453_abnormal_keratinocyte_physiol | 1.13621128 |
| 78 | MP0003705_abnormal_hypodermis_morpholog | 1.13233898 |
| 79 | MP0005332_abnormal_amino_acid | 1.12143696 |
| 80 | MP0003806_abnormal_nucleotide_metabolis | 1.10624788 |
| 81 | MP0002166_altered_tumor_susceptibility | 1.09556581 |
| 82 | MP0000858_altered_metastatic_potential | 1.09114264 |
| 83 | MP0009278_abnormal_bone_marrow | 1.07897559 |
| 84 | MP0003183_abnormal_peptide_metabolism | 1.04103575 |
| 85 | MP0002277_abnormal_respiratory_mucosa | 1.04016870 |
| 86 | MP0006054_spinal_hemorrhage | 1.01555973 |
| 87 | MP0005390_skeleton_phenotype | 0.98715113 |
| 88 | MP0001666_abnormal_nutrient_absorption | 0.97249578 |
| 89 | MP0009333_abnormal_splenocyte_physiolog | 0.95576433 |
| 90 | MP0000716_abnormal_immune_system | 0.93860767 |
| 91 | MP0002933_joint_inflammation | 0.92840530 |
| 92 | MP0003221_abnormal_cardiomyocyte_apopto | 0.91977811 |
| 93 | MP0004019_abnormal_vitamin_homeostasis | 0.91079807 |
| 94 | MP0002332_abnormal_exercise_endurance | 0.89770762 |
| 95 | MP0000015_abnormal_ear_pigmentation | 0.88625751 |
| 96 | MP0005075_abnormal_melanosome_morpholog | 0.87310815 |
| 97 | MP0008004_abnormal_stomach_pH | 0.85915228 |
| 98 | MP0002136_abnormal_kidney_physiology | 0.85527093 |
| 99 | MP0004808_abnormal_hematopoietic_stem | 0.81979074 |
| 100 | MP0002118_abnormal_lipid_homeostasis | 0.81013758 |
| 101 | MP0005257_abnormal_intraocular_pressure | 0.80923257 |
| 102 | MP0001851_eye_inflammation | 0.80741068 |
| 103 | MP0002295_abnormal_pulmonary_circulatio | 0.80697390 |
| 104 | MP0005076_abnormal_cell_differentiation | 0.80580308 |
| 105 | MP0010352_gastrointestinal_tract_polyps | 0.79389462 |
| 106 | MP0001663_abnormal_digestive_system | 0.78399546 |
| 107 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.77437469 |
| 108 | MP0000249_abnormal_blood_vessel | 0.77406980 |
| 109 | MP0001545_abnormal_hematopoietic_system | 0.77300600 |
| 110 | MP0005397_hematopoietic_system_phenotyp | 0.77300600 |
| 111 | MP0009643_abnormal_urine_homeostasis | 0.76815068 |
| 112 | MP0009765_abnormal_xenobiotic_induced | 0.76576107 |
| 113 | MP0000598_abnormal_liver_morphology | 0.76241517 |
| 114 | MP0003045_fibrosis | 0.76170500 |
| 115 | MP0005174_abnormal_tail_pigmentation | 0.75654529 |
| 116 | MP0005408_hypopigmentation | 0.75593190 |
| 117 | MP0003566_abnormal_cell_adhesion | 0.74282885 |
| 118 | MP0003828_pulmonary_edema | 0.72869020 |
| 119 | MP0008438_abnormal_cutaneous_collagen | 0.72802142 |
| 120 | MP0000689_abnormal_spleen_morphology | 0.72001417 |
| 121 | MP0001873_stomach_inflammation | 0.71574248 |
| 122 | MP0004484_altered_response_of | 0.69554221 |
| 123 | MP0002009_preneoplasia | 0.68530110 |
| 124 | MP0003795_abnormal_bone_structure | 0.64367153 |
| 125 | MP0003091_abnormal_cell_migration | 0.62245917 |
| 126 | MP0008874_decreased_physiological_sensi | 0.60536514 |
| 127 | MP0003787_abnormal_imprinting | 0.60466780 |
| 128 | MP0005376_homeostasis/metabolism_phenot | 0.60014628 |
| 129 | MP0001958_emphysema | 0.56294161 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent gram-negative bacterial infections (HP:0005420) | 6.68974810 |
| 2 | Eczematoid dermatitis (HP:0000976) | 6.53095394 |
| 3 | Recurrent abscess formation (HP:0002722) | 6.18295168 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 6.13790713 |
| 5 | Abnormality of macrophages (HP:0004311) | 5.24204374 |
| 6 | Vacuolated lymphocytes (HP:0001922) | 4.54777512 |
| 7 | Gastrointestinal infarctions (HP:0005244) | 4.37201504 |
| 8 | Axonal loss (HP:0003447) | 4.07891116 |
| 9 | Mediastinal lymphadenopathy (HP:0100721) | 3.92562464 |
| 10 | T lymphocytopenia (HP:0005403) | 3.92245024 |
| 11 | Keratoconjunctivitis (HP:0001096) | 3.90898247 |
| 12 | Systemic lupus erythematosus (HP:0002725) | 3.86708665 |
| 13 | Increased cerebral lipofuscin (HP:0011813) | 3.85416741 |
| 14 | Recurrent skin infections (HP:0001581) | 3.79892426 |
| 15 | Abnormality of T cell number (HP:0011839) | 3.77130847 |
| 16 | Meningitis (HP:0001287) | 3.73273157 |
| 17 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.72888943 |
| 18 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.72750341 |
| 19 | Stomatitis (HP:0010280) | 3.71955501 |
| 20 | Disinhibition (HP:0000734) | 3.67802773 |
| 21 | Myocardial infarction (HP:0001658) | 3.65991033 |
| 22 | Gingivitis (HP:0000230) | 3.58916317 |
| 23 | Joint hemorrhage (HP:0005261) | 3.58899533 |
| 24 | Encephalitis (HP:0002383) | 3.57280178 |
| 25 | Glomerulonephritis (HP:0000099) | 3.43076459 |
| 26 | Orchitis (HP:0100796) | 3.33088959 |
| 27 | Obstructive lung disease (HP:0006536) | 3.25333352 |
| 28 | Chronic obstructive pulmonary disease (HP:0006510) | 3.25333352 |
| 29 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.19352712 |
| 30 | Arterial thrombosis (HP:0004420) | 3.19259811 |
| 31 | Myositis (HP:0100614) | 3.17571803 |
| 32 | Peritonitis (HP:0002586) | 3.16571308 |
| 33 | Increased IgE level (HP:0003212) | 3.12535533 |
| 34 | Chest pain (HP:0100749) | 3.11913926 |
| 35 | Xanthomatosis (HP:0000991) | 3.11023383 |
| 36 | Autoimmune thrombocytopenia (HP:0001973) | 3.07782929 |
| 37 | Prolonged partial thromboplastin time (HP:0003645) | 3.06820001 |
| 38 | Thick nail (HP:0001805) | 3.05692097 |
| 39 | Optic neuritis (HP:0100653) | 3.05594000 |
| 40 | Retrobulbar optic neuritis (HP:0100654) | 3.05594000 |
| 41 | Episodic fever (HP:0001954) | 3.00568742 |
| 42 | Leukocytosis (HP:0001974) | 2.96217168 |
| 43 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.95040126 |
| 44 | Prolonged bleeding time (HP:0003010) | 2.93501598 |
| 45 | Complement deficiency (HP:0004431) | 2.92244086 |
| 46 | Abnormality of T cells (HP:0002843) | 2.90956432 |
| 47 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.88327586 |
| 48 | Recurrent fungal infections (HP:0002841) | 2.88291304 |
| 49 | Urticaria (HP:0001025) | 2.84235083 |
| 50 | Abnormality of the common coagulation pathway (HP:0010990) | 2.84159668 |
| 51 | Gangrene (HP:0100758) | 2.79796889 |
| 52 | Pustule (HP:0200039) | 2.77707792 |
| 53 | Epistaxis (HP:0000421) | 2.74802942 |
| 54 | Abnormality of complement system (HP:0005339) | 2.74296507 |
| 55 | Deep venous thrombosis (HP:0002625) | 2.72972992 |
| 56 | Prostate neoplasm (HP:0100787) | 2.72213253 |
| 57 | Hypochromic microcytic anemia (HP:0004840) | 2.66120065 |
| 58 | Intrahepatic cholestasis (HP:0001406) | 2.65586782 |
| 59 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.60568785 |
| 60 | Gingival bleeding (HP:0000225) | 2.59952306 |
| 61 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.59813160 |
| 62 | Dysostosis multiplex (HP:0000943) | 2.59168239 |
| 63 | Interstitial pulmonary disease (HP:0006530) | 2.57722772 |
| 64 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.55451448 |
| 65 | Increased IgM level (HP:0003496) | 2.52360671 |
| 66 | Inflammation of the large intestine (HP:0002037) | 2.51687172 |
| 67 | Periodontitis (HP:0000704) | 2.51434603 |
| 68 | Granulocytopenia (HP:0001913) | 2.51380981 |
| 69 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.50437505 |
| 70 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.50437505 |
| 71 | Abnormality of glycolipid metabolism (HP:0010969) | 2.50437505 |
| 72 | Hypochromic anemia (HP:0001931) | 2.48790896 |
| 73 | Abnormality of the pleura (HP:0002103) | 2.47818567 |
| 74 | Nephritis (HP:0000123) | 2.46549566 |
| 75 | Hematochezia (HP:0002573) | 2.44933625 |
| 76 | Autoimmune hemolytic anemia (HP:0001890) | 2.44734035 |
| 77 | Vasculitis (HP:0002633) | 2.43021387 |
| 78 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.41638293 |
| 79 | Hyperlipoproteinemia (HP:0010980) | 2.41426667 |
| 80 | Amyloidosis (HP:0011034) | 2.41025221 |
| 81 | Gastrointestinal inflammation (HP:0004386) | 2.39451506 |
| 82 | Basal ganglia calcification (HP:0002135) | 2.35099353 |
| 83 | Eosinophilia (HP:0001880) | 2.34441534 |
| 84 | Hepatosplenomegaly (HP:0001433) | 2.34407988 |
| 85 | Abnormality of the peritoneum (HP:0002585) | 2.33151776 |
| 86 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.33016440 |
| 87 | Nausea (HP:0002018) | 2.31253338 |
| 88 | Acute hepatic failure (HP:0006554) | 2.29179047 |
| 89 | Increased serum ferritin (HP:0003281) | 2.28226811 |
| 90 | Glomerulopathy (HP:0100820) | 2.26461431 |
| 91 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.26262426 |
| 92 | Mucopolysacchariduria (HP:0008155) | 2.26262426 |
| 93 | Abnormality of T cell physiology (HP:0011840) | 2.25846858 |
| 94 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.25800091 |
| 95 | Osteolytic defects of the hand bones (HP:0009699) | 2.25800091 |
| 96 | Tetraparesis (HP:0002273) | 2.25794274 |
| 97 | Subacute progressive viral hepatitis (HP:0006572) | 2.24480359 |
| 98 | Hypercholesterolemia (HP:0003124) | 2.24342169 |
| 99 | Sepsis (HP:0100806) | 2.24077834 |
| 100 | Keratitis (HP:0000491) | 2.23254317 |
| 101 | Recurrent bronchitis (HP:0002837) | 2.23097600 |
| 102 | Menorrhagia (HP:0000132) | 2.22664169 |
| 103 | Hydroxyprolinuria (HP:0003080) | 2.20785339 |
| 104 | Abnormality of proline metabolism (HP:0010907) | 2.20785339 |
| 105 | Hypergammaglobulinemia (HP:0010702) | 2.19214124 |
| 106 | Abnormality of iron homeostasis (HP:0011031) | 2.15857431 |
| 107 | Epidermoid cyst (HP:0200040) | 2.15242616 |
| 108 | Bone pain (HP:0002653) | 2.13066686 |
| 109 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.12927598 |
| 110 | Slow saccadic eye movements (HP:0000514) | 2.12355612 |
| 111 | Panhypogammaglobulinemia (HP:0003139) | 2.12226677 |
| 112 | Esophageal varix (HP:0002040) | 2.11427948 |
| 113 | Abnormality of the endocardium (HP:0004306) | 2.10746471 |
| 114 | Microcytic anemia (HP:0001935) | 2.09102451 |
| 115 | Spontaneous hematomas (HP:0007420) | 2.08364324 |
| 116 | Recurrent viral infections (HP:0004429) | 2.08240870 |
| 117 | Pathologic fracture (HP:0002756) | 2.07931230 |
| 118 | Peripheral demyelination (HP:0011096) | 2.07139920 |
| 119 | Cellulitis (HP:0100658) | 2.06642695 |
| 120 | Pulmonary infiltrates (HP:0002113) | 2.06092027 |
| 121 | Acne (HP:0001061) | 2.05803881 |
| 122 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.04797199 |
| 123 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.04797199 |
| 124 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.04797199 |
| 125 | Fat malabsorption (HP:0002630) | 2.04075250 |
| 126 | Upper motor neuron abnormality (HP:0002127) | 2.03349715 |
| 127 | Abnormality of eosinophils (HP:0001879) | 2.02953298 |
| 128 | Osteomyelitis (HP:0002754) | 2.02827196 |
| 129 | Recurrent pneumonia (HP:0006532) | 2.02354158 |
| 130 | Skin ulcer (HP:0200042) | 2.01684975 |
| 131 | Hypobetalipoproteinemia (HP:0003563) | 2.00985355 |
| 132 | Viral hepatitis (HP:0006562) | 2.00710509 |
| 133 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.00601304 |
| 134 | Recurrent cutaneous fungal infections (HP:0011370) | 2.00601304 |
| 135 | Vertigo (HP:0002321) | 2.00524598 |
| 136 | Keratoconjunctivitis sicca (HP:0001097) | 2.00024948 |
| 137 | Lymphopenia (HP:0001888) | 1.99852012 |
| 138 | Colitis (HP:0002583) | 1.98948861 |
| 139 | Pulmonary embolism (HP:0002204) | 1.98602624 |
| 140 | Anorexia (HP:0002039) | 1.98154089 |
| 141 | Conjunctival telangiectasia (HP:0000524) | 1.97332520 |
| 142 | Polyneuropathy (HP:0001271) | 1.96154263 |
| 143 | Vascular calcification (HP:0004934) | 1.95669526 |
| 144 | Abnormality of the pericardium (HP:0001697) | 1.95558477 |
| 145 | Thrombophlebitis (HP:0004418) | 1.94596159 |
| 146 | Joint swelling (HP:0001386) | 1.94446413 |
| 147 | Steatorrhea (HP:0002570) | 1.92830897 |
| 148 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.92387459 |
| 149 | Loss of speech (HP:0002371) | 1.91508250 |
| 150 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.91130933 |
| 151 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.91018316 |
| 152 | Petechiae (HP:0000967) | 1.90449428 |
| 153 | Prolonged neonatal jaundice (HP:0006579) | 1.90136674 |
| 154 | Hemoptysis (HP:0002105) | 1.89272888 |
| 155 | Premature loss of primary teeth (HP:0006323) | 1.87321048 |
| 156 | Cheilitis (HP:0100825) | 1.86287759 |
| 157 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.80310673 |
| 158 | Chronic otitis media (HP:0000389) | 1.79774357 |
| 159 | Skin rash (HP:0000988) | 1.78436183 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.28289699 |
| 2 | PBK | 4.24873248 |
| 3 | MAP3K14 | 3.79222441 |
| 4 | TBK1 | 3.21655229 |
| 5 | IRAK4 | 3.03689437 |
| 6 | IRAK3 | 2.86475113 |
| 7 | BLK | 2.79509775 |
| 8 | ERN1 | 2.71777242 |
| 9 | TYK2 | 2.53019802 |
| 10 | GRK6 | 2.36856214 |
| 11 | NME2 | 2.19215496 |
| 12 | TAOK3 | 2.15714732 |
| 13 | IKBKE | 2.10614438 |
| 14 | JAK3 | 2.08336667 |
| 15 | IKBKB | 2.07880398 |
| 16 | MST4 | 1.95359556 |
| 17 | MST1R | 1.92630731 |
| 18 | PIM2 | 1.83054437 |
| 19 | TXK | 1.71114081 |
| 20 | TNK2 | 1.66839650 |
| 21 | ABL2 | 1.65542716 |
| 22 | TAOK1 | 1.64409669 |
| 23 | KIT | 1.61503836 |
| 24 | CSK | 1.60984570 |
| 25 | MAP4K1 | 1.60482356 |
| 26 | PRPF4B | 1.56774337 |
| 27 | JAK1 | 1.52591172 |
| 28 | FGR | 1.39933069 |
| 29 | MAP3K3 | 1.37945600 |
| 30 | EPHB1 | 1.36160215 |
| 31 | CHUK | 1.33071841 |
| 32 | MAP3K2 | 1.30457914 |
| 33 | RPS6KA4 | 1.25933797 |
| 34 | FRK | 1.21504101 |
| 35 | ZAP70 | 1.20717252 |
| 36 | MAP3K11 | 1.20374606 |
| 37 | ITK | 1.16835545 |
| 38 | NEK9 | 1.15289167 |
| 39 | KSR2 | 1.12755219 |
| 40 | ERBB4 | 1.11873774 |
| 41 | MAP2K3 | 1.10803431 |
| 42 | MAP3K6 | 1.09894470 |
| 43 | SIK3 | 1.09605099 |
| 44 | IRAK2 | 1.09465495 |
| 45 | IRAK1 | 1.07111030 |
| 46 | FGFR4 | 1.05628715 |
| 47 | TGFBR2 | 1.04210893 |
| 48 | JAK2 | 1.02298300 |
| 49 | BMX | 1.02252287 |
| 50 | LYN | 1.01637197 |
| 51 | LCK | 1.00316132 |
| 52 | STK3 | 0.97083744 |
| 53 | CSF1R | 0.95888499 |
| 54 | HCK | 0.95435046 |
| 55 | RIPK1 | 0.95080185 |
| 56 | MATK | 0.94788051 |
| 57 | NUAK1 | 0.92400997 |
| 58 | MET | 0.90549019 |
| 59 | EGFR | 0.88496755 |
| 60 | PTK2B | 0.86647271 |
| 61 | MAP3K5 | 0.86612755 |
| 62 | PIM1 | 0.85967815 |
| 63 | SYK | 0.85945296 |
| 64 | MAP3K13 | 0.84711581 |
| 65 | TRIB3 | 0.82471049 |
| 66 | CAMKK2 | 0.81378536 |
| 67 | MARK2 | 0.79497359 |
| 68 | YES1 | 0.78576909 |
| 69 | TRPM7 | 0.77066974 |
| 70 | EIF2AK2 | 0.76939613 |
| 71 | PDK1 | 0.76816953 |
| 72 | ABL1 | 0.76212162 |
| 73 | BMPR2 | 0.75403609 |
| 74 | STK4 | 0.73238450 |
| 75 | TEC | 0.71485259 |
| 76 | RAF1 | 0.69048989 |
| 77 | STK10 | 0.66804840 |
| 78 | CDK6 | 0.66613750 |
| 79 | MAP2K6 | 0.66342667 |
| 80 | PTK6 | 0.64082498 |
| 81 | BTK | 0.63732848 |
| 82 | PRKCD | 0.63731600 |
| 83 | MAP2K2 | 0.62840217 |
| 84 | FLT3 | 0.62703191 |
| 85 | FGFR3 | 0.62022562 |
| 86 | PIK3CG | 0.61638720 |
| 87 | SGK3 | 0.61353535 |
| 88 | CLK1 | 0.60912693 |
| 89 | MARK3 | 0.60519692 |
| 90 | SGK2 | 0.59908993 |
| 91 | MAP2K4 | 0.59242781 |
| 92 | PRKD2 | 0.57635080 |
| 93 | ACVR1B | 0.55820621 |
| 94 | KSR1 | 0.55738678 |
| 95 | DYRK1B | 0.55005947 |
| 96 | WNK1 | 0.54953396 |
| 97 | NLK | 0.54230821 |
| 98 | HIPK2 | 0.54197078 |
| 99 | LRRK2 | 0.53531135 |
| 100 | SIK1 | 0.53283241 |
| 101 | GRK7 | 0.53092127 |
| 102 | EPHA3 | 0.52300947 |
| 103 | STK38 | 0.51688922 |
| 104 | MAP3K7 | 0.50690818 |
| 105 | TESK2 | 0.49975328 |
| 106 | GSK3A | 0.49774035 |
| 107 | MAPK7 | 0.49141763 |
| 108 | CAMK1D | 0.47085166 |
| 109 | STK11 | 0.46768067 |
| 110 | PDPK1 | 0.46400405 |
| 111 | MAP3K1 | 0.46019749 |
| 112 | PDGFRB | 0.45433200 |
| 113 | CDC42BPA | 0.44392804 |
| 114 | RPS6KA6 | 0.44371700 |
| 115 | BCKDK | 0.44015424 |
| 116 | TAOK2 | 0.43091966 |
| 117 | RET | 0.42358767 |
| 118 | EIF2AK1 | 0.41676307 |
| 119 | EIF2AK3 | 0.40144285 |
| 120 | MAPK12 | 0.40055538 |
| 121 | MAPKAPK2 | 0.39896071 |
| 122 | ARAF | 0.39776856 |
| 123 | DAPK3 | 0.38827072 |
| 124 | PKN2 | 0.36299333 |
| 125 | PRKG2 | 0.34665931 |
| 126 | RPS6KL1 | 0.33562399 |
| 127 | RPS6KC1 | 0.33562399 |
| 128 | INSR | 0.33560697 |
| 129 | DYRK3 | 0.32913408 |
| 130 | PRKCQ | 0.32841446 |
| 131 | FYN | 0.32565907 |
| 132 | GRK5 | 0.32482051 |
| 133 | MOS | 0.31862903 |
| 134 | FES | 0.31756475 |
| 135 | LATS1 | 0.30953245 |
| 136 | CAMKK1 | 0.30406617 |
| 137 | SIK2 | 0.29440874 |
| 138 | STK24 | 0.27659651 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.85846299 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.87037749 |
| 3 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.31820694 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.31174524 |
| 5 | Legionellosis_Homo sapiens_hsa05134 | 2.30763098 |
| 6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.24210862 |
| 7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.22064112 |
| 8 | Malaria_Homo sapiens_hsa05144 | 2.13112596 |
| 9 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.06196627 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.01860289 |
| 11 | Lysosome_Homo sapiens_hsa04142 | 1.97082976 |
| 12 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.96400682 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.96356907 |
| 14 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.95841871 |
| 15 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.90548354 |
| 16 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.89917177 |
| 17 | Pertussis_Homo sapiens_hsa05133 | 1.87890897 |
| 18 | Tuberculosis_Homo sapiens_hsa05152 | 1.85033167 |
| 19 | Phagosome_Homo sapiens_hsa04145 | 1.75076086 |
| 20 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.70973161 |
| 21 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.70222692 |
| 22 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.67578955 |
| 23 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.66659692 |
| 24 | Histidine metabolism_Homo sapiens_hsa00340 | 1.61173708 |
| 25 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.54473298 |
| 26 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.51172323 |
| 27 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.50032869 |
| 28 | Asthma_Homo sapiens_hsa05310 | 1.48600182 |
| 29 | Allograft rejection_Homo sapiens_hsa05330 | 1.34602298 |
| 30 | Measles_Homo sapiens_hsa05162 | 1.31761619 |
| 31 | Other glycan degradation_Homo sapiens_hsa00511 | 1.30015467 |
| 32 | Influenza A_Homo sapiens_hsa05164 | 1.29323705 |
| 33 | Salmonella infection_Homo sapiens_hsa05132 | 1.25338985 |
| 34 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.23996352 |
| 35 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.23940777 |
| 36 | Viral myocarditis_Homo sapiens_hsa05416 | 1.23217908 |
| 37 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.19537113 |
| 38 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.19022370 |
| 39 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.15275368 |
| 40 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.14833984 |
| 41 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.14641246 |
| 42 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.12212280 |
| 43 | Peroxisome_Homo sapiens_hsa04146 | 1.12086606 |
| 44 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.10679747 |
| 45 | Platelet activation_Homo sapiens_hsa04611 | 1.10334154 |
| 46 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.09064762 |
| 47 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.07979097 |
| 48 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.06819880 |
| 49 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.06360886 |
| 50 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.03249449 |
| 51 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.02338769 |
| 52 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.00277403 |
| 53 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.99970795 |
| 54 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.99519549 |
| 55 | Hepatitis C_Homo sapiens_hsa05160 | 0.95143476 |
| 56 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.94348218 |
| 57 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.93591511 |
| 58 | Sulfur relay system_Homo sapiens_hsa04122 | 0.93430028 |
| 59 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.92374479 |
| 60 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.91732695 |
| 61 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.90021982 |
| 62 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.89998728 |
| 63 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.89758023 |
| 64 | Amoebiasis_Homo sapiens_hsa05146 | 0.89663666 |
| 65 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.89061236 |
| 66 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.88778628 |
| 67 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.86133599 |
| 68 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.85932348 |
| 69 | Apoptosis_Homo sapiens_hsa04210 | 0.85014557 |
| 70 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.84342932 |
| 71 | Shigellosis_Homo sapiens_hsa05131 | 0.83343475 |
| 72 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.82974179 |
| 73 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.82423688 |
| 74 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.82196981 |
| 75 | Retinol metabolism_Homo sapiens_hsa00830 | 0.81534327 |
| 76 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.80548026 |
| 77 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.80184670 |
| 78 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.79305704 |
| 79 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.77509564 |
| 80 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.76318020 |
| 81 | Prion diseases_Homo sapiens_hsa05020 | 0.76144495 |
| 82 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.74026868 |
| 83 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.73591438 |
| 84 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.73582239 |
| 85 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.71666655 |
| 86 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.70595668 |
| 87 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.69527861 |
| 88 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.66759752 |
| 89 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.66748185 |
| 90 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.66061313 |
| 91 | Endocytosis_Homo sapiens_hsa04144 | 0.65766641 |
| 92 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.65379771 |
| 93 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.63295994 |
| 94 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.63199481 |
| 95 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.63122834 |
| 96 | Hepatitis B_Homo sapiens_hsa05161 | 0.62119343 |
| 97 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.58949482 |
| 98 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.58348106 |
| 99 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.58314632 |
| 100 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.58148968 |
| 101 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.58056363 |
| 102 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.57621531 |
| 103 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.57483997 |
| 104 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.56417877 |
| 105 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.55679615 |
| 106 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.55086747 |
| 107 | Endometrial cancer_Homo sapiens_hsa05213 | 0.54957775 |
| 108 | Insulin resistance_Homo sapiens_hsa04931 | 0.54599391 |
| 109 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.53702697 |
| 110 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.53626787 |
| 111 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.53503510 |
| 112 | Mineral absorption_Homo sapiens_hsa04978 | 0.52486148 |
| 113 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.51716974 |
| 114 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.50978493 |
| 115 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.50723915 |
| 116 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.50221973 |
| 117 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.50052736 |
| 118 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.48955149 |
| 119 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.48172955 |
| 120 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.47659509 |
| 121 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.47397841 |
| 122 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.47203106 |
| 123 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.46715737 |
| 124 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.46672526 |
| 125 | ABC transporters_Homo sapiens_hsa02010 | 0.46101951 |
| 126 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.44906890 |
| 127 | HTLV-I infection_Homo sapiens_hsa05166 | 0.42762565 |
| 128 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.42227758 |
| 129 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.41907552 |
| 130 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.41633585 |
| 131 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.41444126 |
| 132 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.40719922 |
| 133 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.39355326 |
| 134 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.39244619 |
| 135 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.39117937 |
| 136 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.38552900 |
| 137 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.37394408 |
| 138 | Prostate cancer_Homo sapiens_hsa05215 | 0.35204731 |
| 139 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.35043920 |
| 140 | Colorectal cancer_Homo sapiens_hsa05210 | 0.34731358 |
| 141 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.31732881 |
| 142 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.30213127 |
| 143 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.29198237 |
| 144 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.28164249 |

